期刊文献+

间充质干细胞治疗糖尿病肾病的研究进展 被引量:4

Research progress of mesenchymal stem cells in the treatment of diabetic nephropathy
原文传递
导出
摘要 现有治疗糖尿病肾病的方法包括降血糖、降血压、调脂及抑制肾素-血管紧张素系统等,均不能有效的阻止糖尿病肾病向终末期肾病进展。近年来研究发现,间充质干细胞可能通过调节炎性反应及免疫反应、旁分泌或内分泌各种营养因子、释放细胞外囊泡以及分化为肾固有细胞或与其融合等机制,促进肾脏的修复,从而为糖尿病肾病的治疗提供了新的希望。 Existing methods for treating diabetic nephropathy include glucose control,blood pressure control,lipid-lowering,and renin-angiotensin-aldosterone system blockade,etc.,which are not effective in preventing the progression of diabetic nephropathy to end-stage renal disease.In recent years,studies have found that mesenchymal stem cells may promote kidney repair by regulating inflammatory and immune responses,paracrine or endocrine trophic factors,releasing extracellular vesicles,and differentiating into or integrating with renal innate cells,thus providing new hope for the treatment of diabetic nephropathy.
作者 张洁 汪姣 江妍霞 徐积兄 Zhang Jie;Wang Jiao;Jiang Yanxia;Xu Jixiong(Department of Endocrinology,The First Affiliated Hospital of Nanchang University,Nanchang 330006,China)
出处 《国际内分泌代谢杂志》 2019年第6期394-398,共5页 International Journal of Endocrinology and Metabolism
基金 国家自然科学基金(81760168,81560154) 江西省卫生厅项目(20185092)。
关键词 间充质干细胞 糖尿病肾病 治疗 Mesenchymal stem cells Diabetic nephropathy Treatment
  • 相关文献

参考文献3

二级参考文献17

  • 1Aresu L, Benali S, Garbisa S, et al. Matrix metalloproteinases and their role in the renal epithelial mesenchymal transition [ J ]. Histol His- topathol,2011,26 ( 3 ) : 307-313.
  • 2Lv S, Cheng J, Sun A, et al. Mesenchymal stem cells transplantation a- meliorates glomerular injury in streptozotocin-induced diabetic nephrop- athy in rats via inhibiting oxidative stress[ J]. Diabetes Res Clin Praet, 2014,104( 1 ) : 143-154.
  • 3Zhao TT, Zhang H J, Lu XG, et al. Chaihuang-Yishen granule inhibits di- abetic kidney disease in rats through blocking TGF-beta/Smad3 signa- ling[ J ]. PLoS 0ne,2014,9 (3) : e90807.
  • 4Rabkin R. Diabetic nephropathy[J]. Clin Comerstone, 2003, 5(2): 1-11.
  • 5Iseki K, Kohagura K, Sakima A, et al. Changes in the demographics and prevalence of chronic kidney disease in Okinawa, Japan (1993 to 2003)[J]. Hypertens Res, 2007, 30(1):55-62.
  • 6Choong PF, Mok PL, Cheong SK, et al. Generating neuron- like cells from BM-derived mesenchymal stromal cells in vitro[J]. Cytotherapy, 2007, 9(2): 170-183.
  • 7Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo[J]. Exp Hematol, 2002, 30(1):42-48.
  • 8Devine SM, Bartholomew AM, Mahmud N, et al. Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion[J]. Exp Hematol, 2001, 29(2):244-255.
  • 9Poulsom R, Forbes SJ, Hodivala-Dilke K, et al. Bone marrow contributes to renal parenchymal turnover and regeneration[J]. J Pathol, 2001, 195(2):229-235.
  • 10Krause D, Cantley LG. Bone marrow plasticity revisited: protection or differentiation in the kidney tubule?[J]. J Clin Invest, 2005, 115(7):1705-1708.

共引文献17

同被引文献43

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部